A review examines efforts to identify robust biomarkers that link accumulating senescent cells and their SASP to chronic age-related inflammation and disease.
Key Takeaways
- While one might think that the medical field could forge ahead with therapies targeting senescent cells for clearance
- Drugs that lack such biomarkers will struggle to progress though the regulatory system
- Cellular senescence is the process in which cells lose their ability to proliferate irreversibly